EFFECTS OF ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS ON AMBULATORY BLOOD PRESSURE AND CARDIOVASCULAR FUNCTION IN HYPERTENSIVE PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL DIALYSIS.

Trial Profile

EFFECTS OF ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS ON AMBULATORY BLOOD PRESSURE AND CARDIOVASCULAR FUNCTION IN HYPERTENSIVE PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL DIALYSIS.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Sep 2015

At a glance

  • Drugs Candesartan cilexetil (Primary) ; Valsartan (Primary) ; Antihypertensives
  • Indications Hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Sep 2015 Status changed from active, no longer recruiting to completed, as reported by University Hospital Medical Information Network - Japan record.
    • 03 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top